Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial
| Field | Value |
|---|---|
| Model ID | 14-043-01 |
| Model Name | Whiteley 2014 |
| Pubmed ID | 24603072 |
| First Author | Whiteley |
| Journal | Stroke |
| Year | 2014 |
| Title | Targeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trial |
| Primary Index Condition | Stroke |
| Secondary Index Condition | Ischemic |
| Outcome | Stroke |
| Model Sample Size | 1515 |
| Cohort Sample Size | 1515 |
| Number of Events | 104 |
| Follow-Up Duration | Short (<3 months) |
| AUROC | 0.68 |
| Calibration Reported | 1 |
| Covariates | Age (years); NIHSS; Glucose (mg/dl); Prior hypertension; Atrial fibrillation; Visible infarct on CT; Anti-platelet; Diabetes; Leukoaraiosis; Intercept |
| Mesh Terms | To be updated |
| Number of Validations | 0 |